Risk Evaluation and Mitigation Strategies (REMS) requirements oversee riskier medications and review the serious medication safety concerns frequently. This podcast will review REMS pearls and provide REMS Resources. Join us to learn how to monitor, prevent, and manage serious risks associated with REMS medications.
SPEAKERS
Jed Johnson is a program director for quality, compliance and performance improvement at Vanderbilt University Medical Center Specialty Pharmacy in Nashville, TN. His work focuses on accreditation, drug safety monitoring, and REMS program compliance.
Kate Gordon (she/her) is the pharmacy manager for specialty pharmacy services at Eskenazi Health in Indianapolis, IN. She is responsible for coordinating the formalization of specialty pharmacy services and leading accreditation efforts. Prior to this role, she attended pharmacy school at Butler University and completed postgraduate year 1 and 2 residencies in Health-System Pharmacy Administration and Leadership at the University of Iowa Hospitals and Clinics.
Kate Lewis (she/her) is the Froedtert pharmacy compliance coordinator in Milwaukee, WI. Lewis is responsible for overseeing outpatient pharmacy accreditations (URAC, ACHC, CHAP, and Home Infusion Joint Commission), policies, state and federal regulations. She also is accountable for the student rotations and staffing education. She is an active member of Pharmacy Society of Wisconsin and ASHP.
Rebecca Yoon (she/her) is the director of compliance, quality and performance improvement for specialty pharmacy services at Vanderbilt University Medical Center in Nashville, TN. Her primary responsibilities include leading accreditation processes, overseeing the development of educational training, facilitating quality/compliance/safety initiatives, and managing other quality-related activities such as policy management, auditing, and REMS program participation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.